News

The price of pretomanid, a key component used in the treatment of drug-resistant tuberculosis (TB), dropped by 25% in April, ...
The U.S. Centers for Disease Control and Prevention estimates nearly 13 million people in the U.S. have “latent TB infection.
In a Johns Hopkins Children’s Center study, the addition of navitoclax to the standard TB treatment significantly increased ...
Learn how new TB treatments show higher success rates and fewer side effects with shorter, all-oral regimens. Discover more.
Practecal, a phase 2b-3 randomised controlled trial which identified a new treatment regimen for drug resistant tuberculosis (TB), cost €33.9m (£28.95n; $38.54m), with an average cost of €61 460 per ...
Researchers have developed a chemical probe to study a key component of the Mycobacterium tuberculosis envelope. Their ...
Study Finds Three New Safe, Effective Ways to Treat Drug-Resistant Tuberculosis Jan. 29, 2025 — Study finds three new safe and effective drug regimens to fight multidrug-resistant TB.
Mycobacteria are the world's most deadly bacteria --c ausing infectious diseases including tuberculosis (TB), which alone kills more than one million people each year. New drugs to fight these ...
A new study has identified a potential new therapy for pulmonary tuberculosis that could shorten the length of treatment and ...
A case of tuberculosis was confirmed Tuesday at Dillard High School in Fort Lauderdale, officials said. The Florida Department of Health in Broward County said an individual with active tuberculosis ...
There are many ways to kill microbes that cause dangerous infections. Combining genetic screening with machine learning can ...